Exact Mass: 456.2042452
Exact Mass Matches: 456.2042452
Found 185 metabolites which its exact mass value is equals to given mass value 456.2042452
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Delavirdine
C22H28N6O3S (456.19434980000005)
Delavirdine is only found in individuals that have used or taken this drug. It is a potent, non-nucleoside reverse transcriptase inhibitor with activity specific for HIV-1. [PubChem]Delavirdine binds directly to viral reverse transcriptase (RT) and blocks the RNA-dependent and DNA-dependent DNA polymerase activities by disrupting the enzymes catalytic site. J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
Sudan black B
13-Me ether,3-O-beta-D-glucopyranoside-3,8,13-Trihydroxy-4(15),10(14)-guaiadien-12,6-olide
(8E)-decaene-4,6-diyn-1-O-alpha-L-rhamnopyranosyl-(1->6)-beta-D-glucopyranoside
1-(2-hydroxy-3-O-beta-D-cymaropyranosyl-6-O-beta-D-oleandropyranosyl-phenyl)-ethanone
jatairidoids C|[(1R,3R,4aR,6S,7R,7aS)-6-(acetyloxy)hexahydro-1,4a-dihydroxy-4-methylidene-3,7-epoxycyclopenta[c]pyran-7(1H)-yl]methyl 3-methyl-2-[(3-methylbutanoyl)oxy]butanoate
Ala Glu His Thr
Ala Glu Thr His
Ala Phe Gly Tyr
Ala Phe Tyr Gly
Ala Gly Phe Tyr
Ala Gly Tyr Phe
Ala His Glu Thr
Ala His Thr Glu
Ala Thr Glu His
Ala Thr His Glu
Ala Tyr Phe Gly
Ala Tyr Gly Phe
Asp His Ser Val
Asp His Val Ser
Asp Ser His Val
Asp Ser Val His
Asp Val His Ser
Asp Val Ser His
Glu Ala His Thr
Glu Ala Thr His
Glu His Ala Thr
Glu His Thr Ala
Glu Thr Ala His
Glu Thr His Ala
Phe Ala Gly Tyr
Phe Ala Tyr Gly
Phe Phe Gly Ser
Phe Phe Ser Gly
Phe Gly Ala Tyr
Phe Gly Phe Ser
Phe Gly His Pro
Phe Gly Pro His
Phe Gly Ser Phe
Phe Gly Tyr Ala
Phe His Gly Pro
Phe His Pro Gly
Phe Pro Gly His
Phe Pro His Gly
Phe Ser Phe Gly
Phe Ser Gly Phe
Phe Tyr Ala Gly
Phe Tyr Gly Ala
Gly Ala Phe Tyr
Gly Ala Tyr Phe
Gly Phe Ala Tyr
Gly Phe Phe Ser
Gly Phe His Pro
Gly Phe Pro His
Gly Phe Ser Phe
Gly Phe Tyr Ala
Gly His Phe Pro
Gly His Pro Phe
Gly Pro Phe His
Gly Pro His Phe
Gly Ser Phe Phe
Gly Tyr Ala Phe
Gly Tyr Phe Ala
His Ala Glu Thr
His Ala Thr Glu
His Asp Ser Val
His Asp Val Ser
His Glu Ala Thr
His Glu Thr Ala
His Phe Gly Pro
His Phe Pro Gly
His Gly Phe Pro
His Gly Pro Phe
His Pro Phe Gly
His Pro Gly Phe
His Ser Asp Val
His Ser Val Asp
His Thr Ala Glu
His Thr Glu Ala
His Val Asp Ser
His Val Ser Asp
Pro Phe Gly His
Pro Phe His Gly
Pro Gly Phe His
Pro Gly His Phe
Pro His Phe Gly
Pro His Gly Phe
Ser Asp His Val
Ser Asp Val His
Ser Phe Phe Gly
Ser Phe Gly Phe
Ser Gly Phe Phe
Ser His Asp Val
Ser His Val Asp
Ser Val Asp His
Ser Val His Asp
Thr Ala Glu His
Thr Ala His Glu
Thr Glu Ala His
Thr Glu His Ala
Thr His Ala Glu
Thr His Glu Ala
Val Asp His Ser
Val Asp Ser His
Val His Asp Ser
Val His Ser Asp
Val Ser Asp His
Val Ser His Asp
Tyr Ala Phe Gly
Tyr Ala Gly Phe
Tyr Phe Ala Gly
Tyr Phe Gly Ala
Tyr Gly Ala Phe
Tyr Gly Phe Ala
17-trifluoromethylphenyl trinor PGF2&alpha
Levocabastine hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
1-methoxy-3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol,dihydrochloride
C23H34Cl2N2O3 (456.19463540000004)
3-Quinolineacetic acid, 4-(2,3-dihydropyrano[4,3,2-de]quinolin-7-yl)-α-(1,1-dimethylethoxy)-2-methyl-, methyl ester, (αS,4R)-
C28H28N2O4 (456.20489680000003)
N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclopentylamino)-2-oxoethyl]-N-(5-methyl-3-isoxazolyl)butanediamide
1-[1-[[1-[(4-Methylphenyl)methyl]-5-tetrazolyl]methyl]-4-piperidinyl]-5-(trifluoromethyl)benzotriazole
[(8S,9S,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9S,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9R,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
N-[(2R,4aR,12aR)-2-[2-(ethylamino)-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-5-methyl-3-isoxazolecarboxamide
2-[(3S,6aS,8R,10aS)-1-[(2-fluorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(phenylmethyl)acetamide
(3aR,4R,9bS)-8-(4-cyanophenyl)-N-(3-fluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
C27H25FN4O2 (456.19614419999994)
[(8R,9R,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8R,9S,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9S,10S)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(8S,9R,10R)-6-(4-methoxyphenyl)sulfonyl-9-[4-[(E)-prop-1-enyl]phenyl]-1,6-diazabicyclo[6.2.0]decan-10-yl]methanol
[(2S,3R)-1-(4-oxanylmethyl)-3-phenyl-6-(phenylmethyl)sulfonyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] octanoate
C19H37O10P (456.21242320000005)
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] octanoate
C19H37O10P (456.21242320000005)
[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] heptanoate
C19H37O10P (456.21242320000005)
[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] nonanoate
C19H37O10P (456.21242320000005)
[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] decanoate
C19H37O10P (456.21242320000005)
[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] undecanoate
C19H37O10P (456.21242320000005)
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] heptanoate
C19H37O10P (456.21242320000005)
[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] nonanoate
C19H37O10P (456.21242320000005)
[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] decanoate
C19H37O10P (456.21242320000005)
[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] undecanoate
C19H37O10P (456.21242320000005)
Delavirdine
C22H28N6O3S (456.19434980000005)
J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AG - Non-nucleoside reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent
phosphatidylglycerol 13:0
C19H37O10P (456.21242320000005)
A phosphatidylglycerol in which the two acyl groups contain 13 carbon atoms and no double bonds
P2X3 antagonist 34
C24H26F2N4O3 (456.19728699999996)
P2X3 antagonist 34 is a potent, selective and orally active P2X3 homotrimeric receptor antagonist with IC50s of 25?nM, 92?nM and 126?nM for human P2X3, rat P2X3 and guinea pig P2X3 receptors, respectively. P2X3 antagonist 34 is less active against human, rat and guinea pig P2X2/3 heterotrimeric receptors. P2X3 antagonist 34 has strong anti-tussive effect[1].
(2r,3r,4s,5s,6r)-2-[(8e)-dec-8-en-4,6-diyn-1-yloxy]-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(3,4,5-trihydroxy-6-{[2-(4-hydroxycyclohex-1-en-1-yl)acetyl]oxy}oxan-2-yl)methyl 2-(4-hydroxycyclohex-1-en-1-yl)acetate
(3r,3ar,4r,6ar,8s,9ar,9br)-4-hydroxy-3-(methoxymethyl)-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3h-azuleno[4,5-b]furan-2-one
4-deacetyltaxagifine iii
{"Ingredient_id": "HBIN010310","Ingredient_name": "4-deacetyltaxagifine iii","Alias": "NA","Ingredient_formula": "C22H32O10","Ingredient_Smile": "CC(=O)OC1CC2C(CO2)(C3C1(C(=O)C(C4(C5(COC4(C(CC5C3O)O)C)C)O)O)C)O","Ingredient_weight": "456.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4777","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101607468","DrugBank_id": "NA"}